Steriscience Drug Patent Portfolio
Steriscience owns 1 orange book drug protected by 3 US patents Given below is the list of Steriscience's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11065256 | Administration and dosage of diaminophenothiazines | 11 Jan, 2039 | Active |
| US11065265 | Compositions of fosaprepitant and methods of preparation | 11 Jan, 2039 | Active |
| US12042504 | Injectable fosaprepitant composition | 11 Jan, 2039 | Active |
Latest Legal Activities on Steriscience's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Steriscience.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Jul, 2021 | US11065265 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Jul, 2021 | US11065265 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Jul, 2021 | US11065256 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Jul, 2021 | US11065256 |
|
Email Notification
Critical
| 01 Jul, 2021 | US11065265 |
|
Email Notification
Critical
| 01 Jul, 2021 | US11065256 |
|
Issue Notification Mailed
Critical
| 30 Jun, 2021 | US11065256 |
|
Issue Notification Mailed
Critical
| 30 Jun, 2021 | US11065265 |
|
Email Notification
Critical
| 25 Jun, 2021 | US11065256 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 25 Jun, 2021 | US11065256 |
| Printer Rush- No mailing | 25 Jun, 2021 | US11065256 |
| Dispatch to FDC | 24 Jun, 2021 | US11065256 |
|
Application Is Considered Ready for Issue
Critical
| 17 Jun, 2021 | US11065256 |
|
Application Is Considered Ready for Issue
Critical
| 17 Jun, 2021 | US11065265 |
| Dispatch to FDC | 17 Jun, 2021 | US11065265 |
Steriscience's Family Patents
Steriscience Drug List
Given below is the complete list of Steriscience's drugs and the patents protecting them.
1. Focinvez
Focinvez is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11065256 | Administration and dosage of diaminophenothiazines |
11 Jan, 2039
(14 years from now)
| Active |
| US11065265 | Compositions of fosaprepitant and methods of preparation |
11 Jan, 2039
(14 years from now)
| Active |
| US12042504 | Injectable fosaprepitant composition |
11 Jan, 2039
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Focinvez's drug page